Cosette Pharmaceuticals and Mayne Pharma have ended their $430M acquisition deal following a court ruling and disputes over alleged breaches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback